Evidence map›Paper›PMID 31381170›Full record

ArticleAlcoholism, clinical and experimental research2019

Response to Dr. Mark Litt's Commentary.

Raymond F Anton, Katie Witkiewitz, Daniel Falk, Raye Litten, Deborah Hasin, Karl Mann, Stephanie O'Malley, Alcohol Clinical Trials Initiative (ACTIVE) Group

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Alcoholism, clinical and experimental research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Raymond F AntonFrom the, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0003-3417-6576
Katie WitkiewitzThe University of New Mexico, Albuquerque, New Mexico.ORCID 0000-0002-1086-3067
Daniel FalkNational Institutes of Health - National Institute on Alcohol & Alcoholism, Rockville, Maryland.ORCID 0000-0002-3753-2786
Raye LittenNational Institutes of Health - National Institute on Alcohol & Alcoholism, Rockville, Maryland.
Deborah HasinColumbia University, New York, New York.
Karl MannUniversity of Heidelberg, Mannheim, Germany.ORCID 0000-0002-2087-1976
Stephanie O'MalleyYale University, New Haven, Connecticut.
Alcohol Clinical Trials Initiative (ACTIVE) Group

Funding

Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints - Administrative SupplementR01AA025309 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2016 to 2021
$925k
NIAAA NIH HHS R01 AA025309
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlcoholismAlcohol DrinkingHumansWorld Health Organization

Identifiers

PMID31381170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.